1. Home
  2. NMP vs BHST Comparison

NMP vs BHST Comparison

Compare NMP & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMP
  • BHST
  • Stock Information
  • Founded
  • NMP 2024
  • BHST 2007
  • Country
  • NMP United States
  • BHST Canada
  • Employees
  • NMP N/A
  • BHST N/A
  • Industry
  • NMP Blank Checks
  • BHST
  • Sector
  • NMP Finance
  • BHST
  • Exchange
  • NMP Nasdaq
  • BHST Nasdaq
  • Market Cap
  • NMP 159.9M
  • BHST 153.4M
  • IPO Year
  • NMP 2025
  • BHST N/A
  • Fundamental
  • Price
  • NMP $10.04
  • BHST $7.11
  • Analyst Decision
  • NMP
  • BHST Strong Buy
  • Analyst Count
  • NMP 0
  • BHST 2
  • Target Price
  • NMP N/A
  • BHST $13.00
  • AVG Volume (30 Days)
  • NMP 55.9K
  • BHST 107.1K
  • Earning Date
  • NMP 01-01-0001
  • BHST 11-13-2025
  • Dividend Yield
  • NMP N/A
  • BHST N/A
  • EPS Growth
  • NMP N/A
  • BHST N/A
  • EPS
  • NMP N/A
  • BHST N/A
  • Revenue
  • NMP N/A
  • BHST $30,192,000.00
  • Revenue This Year
  • NMP N/A
  • BHST $116.40
  • Revenue Next Year
  • NMP N/A
  • BHST $55.91
  • P/E Ratio
  • NMP N/A
  • BHST N/A
  • Revenue Growth
  • NMP N/A
  • BHST 57.83
  • 52 Week Low
  • NMP $9.90
  • BHST $4.72
  • 52 Week High
  • NMP $10.07
  • BHST $12.80
  • Technical
  • Relative Strength Index (RSI)
  • NMP N/A
  • BHST 38.17
  • Support Level
  • NMP N/A
  • BHST $6.20
  • Resistance Level
  • NMP N/A
  • BHST $8.14
  • Average True Range (ATR)
  • NMP 0.00
  • BHST 1.08
  • MACD
  • NMP 0.00
  • BHST -0.30
  • Stochastic Oscillator
  • NMP 0.00
  • BHST 18.83

About NMP NMP Acquisition Corp. Class A Ordinary Shares

NMP Acquisition Corp is a blank check company.

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: